Abdolmaleki, A., Jalili, C., Mansouri, K., & Bakhtiari, M. (2021). New rat to mouse xenograft transplantation of endometrium as a model of human endometriosis. Animal Models and Experimental Medicine, 4(3), 268-277.
Adewole, K. E., Attah, A. F., & Osawe, S. O. (2023). Exploring phytotherapeutic approach in the management of valproic acid-induced toxicity. Advances in Traditional Medicine, 23(2), 347-367.
Cai, H., Zou, J., Wang, W., & Yang, A. (2021). BMP2 induces hMSC osteogenesis and matrix remodeling. Molecular Medicine Reports, 23(2), 1-1.
Duncan, S. (2007). Teratogenesis of sodium valproate. Current opinion in neurology, 20(2), 175-180.
Gebuijs, I. G. E., Metz, J. R., Zethof, J., Carels, C. E. L., Wagener, F. A. D. T. G., & Von den Hoff, J. W. (2020). The anti-epileptic drug valproic acid causes malformations in the developing craniofacial skeleton of zebrafish larvae. Mechanisms of Development, 163, 103632.
Gruppuso, P. A., Ahmed, R., & Adashi, E. Y. (2022). Valproate Teratogenicity: A Moving Target. Obstetrics & Gynecology, 140(3), 408-411.
Holmes, L. B. (2002). Teratogen‐induced limb defects. American journal of medical genetics, 112(3), 297-303.
Jahromi, M. A. F., Etemadfard, H., & Zebarjad, Z. (2018). Antimicrobial and antioxidant characteristics of volatile components and ethanolic fruit extract of Prosopis farcta (Bank & Soland.). Trends in Pharmaceutical Sciences, 4(3), 177-186.
Khan, S., & Jena, G. B. (2013). Effect of sodium valproate on the toxicity of cyclophosphamide in the testes of mice: influence of pre- and post-treatment schedule. Toxicol Int, 20(1), 68-76. doi:10.4103/0971-6580.111562
Kim, W.-J., Shin, H.-L., Kim, B.-S., Kim, H.-J., & Ryoo, H.-M. (2020). RUNX2-modifying enzymes: therapeutic targets for bone diseases. Experimental & Molecular Medicine, 52(8), 1178-1184.
Kirihata, Y., Ban, Y., Nakamori, C., Takagi, H., Hashimoto, T., & Tsutsumi, S. (2018). Repairability of skeletal alterations induced by sodium valproate in rats. Congenital Anomalies, 58(3), 99-101.
Komori, T. (2019). Regulation of proliferation, differentiation and functions of osteoblasts by Runx2. International Journal of Molecular Sciences, 20(7), 1694.
Macfarlane, A., & Greenhalgh, T. (2018). Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach? BMC pregnancy and childbirth, 18(1), 1-11.
Massa, V., Cabrera, R. M., Menegola, E., Giavini, E., & Finnell, R. H. (2005). Valproic acid-induced skeletal malformations: associated gene expression cascades. Pharmacogenetics and genomics, 15(11), 787-800.
Menegola, E., Broccia, M. L., Di Renzo, F., & Giavini, E. (2002). Comparative study of sodium valproate-induced skeletal malformations using single or double staining methods. Reproductive Toxicology, 16(6), 815-823.
Mohammed, I. H., & Kakey, E. S. (2020). Effect of Prosopis farcta extracts on some complications (hematology and lipid profiles) associated with alloxan induced diabetic rats. Iraqi J Vet Sci, 34(1), 45-50.
Najafzadeh, V. H., & Khaksari, M. M. (2009). A comparison study of the effects of Echinacea purpurea ethanolic extract and mesna on cyclophosphamide-induced macroscopic fetal defects in rats.
Nie, Q., Su, B., & Wei, J. (2016). Neurological teratogenic effects of antiepileptic drugs during pregnancy. Experimental and therapeutic medicine, 12(4), 2400-2404. doi:10.3892/etm.2016.3628
Noroozi, R., Sadeghi, E., Yousefi, H., Taheri, M., Sarabi, P., Dowati, A., . . . Ghafouri-Fard, S. (2019). Wound healing features of Prosopis farcta: in vitro evaluation of antibacterial, antioxidant, proliferative and angiogenic properties. Gene Reports, 17, 100482.
Ornoy, A., Becker, M., Weinstein-Fudim, L., & Ergaz, Z. (2020). S-adenosine methionine (SAME) and valproic acid (VPA) as epigenetic modulators: Special emphasis on their interactions affecting nervous tissue during pregnancy. International Journal of Molecular Sciences, 21(10), 3721.
Ovchinnikov, D. (2009). Alcian blue/alizarin red staining of cartilage and bone in mouse. Cold Spring Harb Protoc, 2009(3).
Padmanabhan, R., & Ahmed, I. (1996). Sodium valproate augments spontaneous neural tube defects and axial skeletal malformations into mouse fetuses. Reproductive Toxicology, 10(5), 345-363.
Pitetzis, D. A., Spilioti, M. G., Yovos, J. G., & Yavropoulou, M. P. (2017). The effect of VPA on bone: From clinical studies to cell cultures—The molecular mechanisms revisited. Seizure, 48, 36-43.
Procópio, I. M., Pereira-Sampaio, M. A., Costa, W. S., Sampaio, F. J. B., & Souza, D. B. d. (2021). Histomorphometric comparison of the corpus cavernosum of rats submitted to euthanasia with ketamine and xylazine or isoflurane. Acta Cirúrgica Brasileira, 36, e361103.
Rahgazar, O., Ranjbar, R., Varzi, H. N., & Mahabady, M. K. (2011). Prophylactic effects of melatonin on sodium valproate-induced neural tube defects and skeletal malformations in rat embryos. American Journal of Applied Sciences, 8(5), 413.
Saeed, M., Saleem, U., Anwar, F., Ahmad, B., & Anwar, A. (2020). Inhibition of Valproic Acid-Induced Prenatal Developmental Abnormalities with Antioxidants in Rats. ACS Omega, 5(10), 4953-4961. doi:10.1021/acsomega.9b03792
Safdar, A., & Ismail, F. (2023). A comprehensive review on pharmacological applications and drug-induced toxicity of valproic acid. Saudi Pharmaceutical Journal, 31(2), 265-278.
Shakya, P., Shakya, N. K., & Mohanty, C. (2020). Teratogenic effects (resorptions and reduction in weight and crown rump length) of valproate on fetal mice. National Journal of Clinical Anatomy, 9(2), 39.
Sultana, S., Doshi, M., Jayasree, N., & Chandrupatla, M. (2019). Comparative study of drug damage caused on Cerebrum in Chick Embryos administered with Drugs-Cyclophosphamide and Sodium Valproate. Journal of Pharmaceutical Sciences and Research, 11(7), 2774-2777.
Vafaee-Shahi, M., Soheilipour, F., Mohagheghi, P., Riahi, A., Borghei, N.-S., & Talebi, A. (2022). Effect of Sodium Valproate on Weight, Body Mass Index, Uric Acid, Vitamin D3, Blood Insulin, and Serum Lipid Profile in Children. The Open Neurology Journal, 16(1).
